Fresenius Medical Care AG & Co. KGaA (ADR) (NYSE:FMS)

CAPS Rating: 5 out of 5

The Company is engaged in the manufacture and sale of products for all forms of kidney dialysis, to health care providers throughout the world, and in providing kidney dialysis treatment and other medical ancillary services.


Player Avatar OklaBoston (68.01) Submitted: 3/9/2013 8:20:28 PM : Underperform Start Price: $34.09 FMS Score: -5.66

Unusual harmony between fundamentals and charts here. Book value is only $15 here and this could well be trading that low or lower in less than a year.

Featured Broker Partners